Genscript Biotech(HK:1548)
HK$31.84-2.90 (-8.35%)
HK:1548
Genscript Biotech ownership
HK$31.84
At close:-2.90 (-8.35%)
Want to see HK:1548 full AI Analyst Report?
Genscript Biotech (1548) Ownership - Who Owns Genscript Biotech?
12 Followers
Genscript Biotech (1548) Ownership Overview
- 3.04% Mutual Funds
- 6.61% ETFs
- 90.35% Public Companies and Individual Investors
The ownership structure of Genscript Biotech (HK:1548) stock is a mix of institutional, retail, and individual investors. Approximately 9.65% of the company’s stock is owned by Institutional Investors, and 90.35% is owned by Public Companies and Individual Investors.
The ownership structure of Genscript Biotech (HK:1548) stock is a mix of institutional, retail, and individual investors. Approximately 9.65% of the company’s stock is owned by Institutional Investors, and 90.35% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Ishares | 52,423,236 | Institution | 2.30% | 212,733,492 |
| Vanguard | 42,675,581 | Institution | 1.87% | 173,177,508 |
| Vanguard International Equity Index Funds | 21,035,916 | Institution | 0.92% | 85,363,747 |
| Vanguard Star Funds | 17,724,403 | Institution | 0.78% | 71,925,627 |
| Amundi | 12,307,298 | Institution | 0.54% | 49,943,015 |
| Ubs | 8,914,829 | Institution | 0.39% | 36,176,376 |
| Avantis | 7,674,000 | Institution | 0.34% | 31,141,092 |
| Fidelity Rutland Square Trust Ii | 6,244,981 | Institution | 0.27% | 25,342,133 |
| T. Rowe Price International Funds, Inc. | 5,994,000 | Institution | 0.26% | 24,323,652 |
| Fidelity Salem Street Trust | 5,844,993 | Institution | 0.26% | 23,718,982 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard International Equity Index Funds | 21,035,916 | Institution | 0.92% | 85,363,747 |
| Vanguard Star Funds | 17,724,403 | Institution | 0.78% | 71,925,627 |
| Fidelity Rutland Square Trust Ii | 6,244,981 | Institution | 0.27% | 25,342,133 |
| T. Rowe Price International Funds, Inc. | 5,994,000 | Institution | 0.26% | 24,323,652 |
| Fidelity Salem Street Trust | 5,844,993 | Institution | 0.26% | 23,718,982 |
| Dfa Investment Dimensions Group Inc | 5,700,000 | Institution | 0.25% | 23,130,600 |
| Tiaa-cref Funds | 1,944,000 | Institution | 0.09% | 7,888,752 |
| Matthews International Funds | 1,354,000 | Institution | 0.06% | 5,494,532 |
| Goldman Sachs Trust | 1,240,000 | Institution | 0.05% | 5,031,920 |
| Northern Funds | 564,000 | Institution | 0.02% | 2,288,712 |
Top ETF Holders
FAQ
What percentage of Genscript Biotech (HK:1548) stock is held by institutional investors?
According to the latest TipRanks data, approximately 9.65% of Genscript Biotech (HK:1548) stock is held by institutional investors: 3.04% by mutual funds and 6.61% by ETFs.
What percentage of Genscript Biotech (HK:1548) stock is held by retail investors?
According to the latest TipRanks data, approximately 90.35% of Genscript Biotech (HK:1548) stock is held by public companies and individual investors.
Who owns the most shares of Genscript Biotech (HK:1548)?
iShares owns the most shares of Genscript Biotech (HK:1548).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
